Abstract | Background: Case summary: We report a case of acute pericarditis after the second dose of mRNA COVID-19 vaccine with recurrence of large pericardial effusion after a previous pericardiocentesis and anti-inflammatory drugs tapering. The patient was successfully treated with the recombinant interleukin-1 receptor antagonist anakinra, with full reabsorption of the pericardial effusion and an abrupt drop of the inflammatory markers within 72 h. The patient was discharged a few days later, with a further decrease of the inflammatory markers and no residual symptoms. Discussion:
|
Authors | Francesco Perna, Elena Verecchia, Gaetano Pinnacchio, Laura Gerardino, Antonio Brucato, Raffaele Manna |
Journal | European heart journal. Case reports
(Eur Heart J Case Rep)
Vol. 6
Issue 4
Pg. ytac123
(Apr 2022)
ISSN: 2514-2119 [Electronic] England |
PMID | 35445166
(Publication Type: Case Reports)
|
Copyright | © The Author(s) 2022. Published by Oxford University Press on behalf of European Society of Cardiology. |